Lissencephaly and Periventricular Heterotopia
Lissencephaly (LIS)
LIS is a neuronal migration disorder and represents a malformation spectrum resulting from mutations of either LIS1 or DCX genes. In severe LIS, the cortex lacks surface folds. At the same time, manifestations include abnormally broad folds or a heterotopic layer of gray matter embedded in the white matter below the cortex.
Fig.1 The classical lissencephaly spectrum. (Fry, 2014)
Key Factors for LIS
Malformation syndromes such as LIS have been recognized, and specific causative gene defects have been identified in recent years. Five genes have been identified that cause or contribute to LIS in humans: LIS1, DCX, RELN, ARX, and TUBA1A.
LIS1 | The LIS1 gene is the first gene associated with LIS, and its mutations cause severe malformation posteriorly. |
DCX | DCX (also known as XLIS) is the second major gene associated with LIS. DCX mutations can cause the spectrum of LIS in males. Women with this mutation classically have a migration disorder called SBH. |
RELN | The gene encoding the receptor for RELN, a very low-density lipoprotein receptor (VLDLR), is also shown to be causative for LIS. In patients, Autosomal recessive LIS, accompanied by severe delay, cerebellar hypoplasia, and seizures, is associated with mutations of RELN. |
ARX | ARX mutations cause a series of neurologic diseases, such as LIS with anomalous genitalia and severe epilepsy. |
TUBA1A | TUBA1A is also a causative gene for LIS disease. Patients with TUBA1A mutations have many additional defects that are less commonly associated with LIS1 and DCX mutations, such as hypoplasia of the anterior limb of the internal capsule. |
Fig.2 Genetic heterogeneity in lissencephaly. (Fry, 2014)
Periventricular Heterotopia
Periventricular nodular heterotopia (PH) is a heterogeneous group of malformations in which more profound heterotopic neurons are observed. PH features the subset of neurons that line the walls of lateral ventricles after failing to migrate completely into the cerebral cortex.
This malformation may involve both sides of the brain or be restricted to a single hemisphere less frequently. They can occur singly or combined with other findings, including polymicrogyria, microcephaly, hydrocephalus, and limb abnormalities. PH can be caused by genetic mutations (e.g., FilaminA, ARFGEF2) or extrinsic factors (e.g., irradiation, infection, injury). Seizures are the most common presenting feature.
Key Factors for PH
PH is caused by genetic mutations or extrinsic factors, such as infections or prenatal injuries; PH has previously been identified with amniotic band syndrome in some clinical cases. Two genes are already known to cause PH: filaminA (FLNA) and adenosine diphosphate-ribosylation factor guanine exchange factor 2 (ARFGEF2). FLNA mutations are reported in all familial X-linked PH and approximately 25% of sporadic cases. Rare patients of both genders with FLN1 mutations had unilateral PH. In addition, patients with mutations of the ARFGEF2 gene present microcephaly, slightly enlarged ventricles, and delayed myelination. The X-linked dominant form of PH is caused by mutations in FLNA, whereas mutations cause the autosomal recessive form of PH and microcephaly in ARFGEF2.
Fig.3 Representative MRI section of PH in a patient with FILNA mutations. (Nadia Bahi-Buisson, 2013)
Products Provided by Creative Biolabs
Creative Biolabs has hugely experienced specialists working alongside our teams, providing expert advice and an enormous breadth of advanced technologies. Our high-quality products and services include vectors, cell lines, proteins & peptides, and antibodies, and animal models for your research. The LIS and PH related products are as following:
DCX | RELN | VLDLR |
LIS1 | ARX | TUBA1A |
To see more detailed information on our products, please directly send us your inquiry.
References
- Fry, A. E.; et al. The genetics of lissencephaly. In American Journal of Medical Genetics Part C: Seminars in Medical Genetics (Vol. 166, No. 2, pp. 198-210). 2014, June.
- Bahi-Buisson, N.; Guerrini, R. Diffuse malformations of cortical development. Handbook of clinical neurology. 2013, 111, 653-665.
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- NeuroMab™ Anti-Alpha Synuclein BBB Shuttle Antibody(NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- NeuroMab™ Anti-pTau Antibody(NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- NeuroMab™ Anti-Amyloid Beta 1-15 Antibody(NRP-0422-P867) (Cat#: NRP-0422-P867)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P517) (Cat#: NRP-0422-P517)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Green Fluorescent Tau SH-SY5Y cell Line (Cat#: NCL2110P219)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- pAAV-syn-FLEX-jGCaMP8m-WPRE (Cat#: NTA-2106-P065)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)